RT book part T1 Deep Brain Stimulation: Mechanisms Underpinning Antidepressant Effects. A1 Torres Sánchez, Sonia A1 Perez-Caballero, Laura A1 Berrocoso Domínguez, Esther María A2 Neurociencias A2 Psicología AB Major depressive disorder (MDD) is a severe and common psychiatric illness with a high prevalence and is the leading cause of disability worldwide [1]. Despite our advances in understanding the pathophysiology of depression and the wide range of therapeutic options available, not all patients affected respond successfully to such treatments. Thus, 30%–40% of patients fail to respond to first-line treatments and between 5% and 10% also fail to respond to more aggressive therapies [2, 3]. This urgent need for more effective treatments led to the proposal that deep brain stimulation (DBS) may be a suitable alternative technique to treat refractory MDD patients. This therapy was originally developed for movement disorders, and currently, its use is approved by the US Food and Drugs Administration to treat essential tremor (1997), Parkinson disease (2002), dystonia (2003), and obsessive-compulsive disorder (2009). In addition, DBS is being tested to treat neurological pathologies other than MDD, such as anorexia nervosa or addiction. DBS is an innovative technique based on the intracranial implantation of stimulation electrodes that are permanently connected to a neurostimulator in order to deliver chronic electrical impulses that stimulate specific brain regions. This invasive technique implies stereotaxic surgery, yet the experience acquired over the past few decades indicates that this is a safe and well-tolerated therapy. The principal advantages of DBS compared to other approaches are the reversibility and the possibility of adjusting the stimulation parameters to achieve the required therapeutic effect as a function of the individual patient’s needs.The mechanism of action of DBS has not yet been defined, although efforts are ongoing to shed light on the events that underlie the therapeutic benefits associated to DBS. It was originally thought that, like classic ablative surgery, DBS produced its therapeutic effect by reducing activity in the target area. Nevertheless, following studies have shown that DBS restores brain activity and connectivity through neuromodulation, inducing long-term effects that may involve anatomical reorganization of the circuits affected [4]. In this chapter, the most relevant evidence regarding the mechanisms underlying the antidepressant effect of DBS when delivered to the main targets used will be reviewed. PB Elsevier SN 978-0-12-813333-0 YR 2019 FD 2019 LK http://hdl.handle.net/10498/34963 UL http://hdl.handle.net/10498/34963 LA eng DS Repositorio Institucional de la Universidad de Cádiz RD 19-nov-2026